Literature DB >> 9030536

Biophysical and biological properties of naturally occurring high molecular weight insulin-like growth factor II variants.

K J Valenzano1, E Heath-Monnig, S E Tollefsen, M Lake, P Lobel.   

Abstract

A soluble form of the insulin-like growth factor II/mannose 6-phosphate receptor (sIGF-II/MPR) is present in fetal bovine serum and carries mature 7.5-kDa insulin-like growth factor II (IGF-II) and at least 12 different high molecular weight (Mr) IGF-II isoforms (Valenzano, K. J., Remmler, J., and Lobel, P. (1995) J. Biol. Chem. 270, 16441-16448). In this study, we used gel filtration and anion exchange chromatographies to resolve the isoforms into eight fractions that were characterized with respect to their biochemical, biophysical, and biological properties. Each fraction contained one to three major protein species with apparent sizes ranging from 11 to 17 kDa by SDS-polyacrylamide gel electrophoresis. The 11-kDa species contains no post-translational modifications and consists of an extended IGF-II backbone terminating at Gly-87. The remaining high Mr IGF-II isoforms are also composed of an 87-amino acid IGF-II peptide backbone but contain increasing amounts of sialated, O-linked sugars. Plasmon resonance spectroscopy experiments revealed that all the high Mr isoforms and mature 7.5-kDa IGF-II bound to immobilized recombinant soluble human IGF-I receptor, recombinant human IGF-binding protein 1, and sIGF-II/MPR with similar kinetics. In addition, radiolabeled tracer experiments demonstrated that both mature and high Mr IGF-II isoforms have similar binding profiles in fetal bovine serum and have similar affinities for IGF-II-binding proteins secreted from human fibroblasts. Finally, the biological activity of high Mr IGF-II was shown to be similar to or slightly better than mature IGF-II in stimulating amino acid uptake in fibroblasts and in inducing myoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030536     DOI: 10.1074/jbc.272.8.4804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Plasma distribution and signaling activities of IGF-II precursors.

Authors:  Alicia G Marks; Julie M Carroll; Jonathan Q Purnell; Charles T Roberts
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

2.  A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice.

Authors:  Sven Müller-Loennies; Giovanna Galliciotti; Katrin Kollmann; Markus Glatzel; Thomas Braulke
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

Authors:  S Khosla; A A Hassoun; B K Baker; F Liu; N N Zein; M P Whyte; C A Reasner; T B Nippoldt; R D Tiegs; R L Hintz; C A Conover
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Role of pro-IGF-II processing by proprotein convertase 4 in human placental development.

Authors:  Qing Qiu; Ajoy Basak; Majambu Mbikay; Benjamin K Tsang; Andrée Gruslin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

5.  Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer.

Authors:  Marco Archetti; Daniela A Ferraro; Gerhard Christofori
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

6.  Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer.

Authors:  Sameer A Greenall; John D Bentley; Lesley A Pearce; Judith A Scoble; Lindsay G Sparrow; Nicola A Bartone; Xiaowen Xiao; Robert C Baxter; Leah J Cosgrove; Timothy E Adams
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

7.  Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction.

Authors:  Hong Wa Yung; Myriam Hemberger; Erica D Watson; Claire E Senner; Carolyn P Jones; Randal J Kaufman; D Stephen Charnock-Jones; Graham J Burton
Journal:  J Pathol       Date:  2012-09-28       Impact factor: 7.996

8.  Glycosylation-independent lysosomal targeting of acid α-glucosidase enhances muscle glycogen clearance in pompe mice.

Authors:  John A Maga; Jianghong Zhou; Ravi Kambampati; Susan Peng; Xu Wang; Richard N Bohnsack; Angela Thomm; Sarah Golata; Peggy Tom; Nancy M Dahms; Barry J Byrne; Jonathan H LeBowitz
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.